John Baldoni serves as Executive at MiNK Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John Baldoni has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 1, 2023 involved receiving (via award) 9,846 shares valued at $14.4K.
John Baldoni currently holds 41,193 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Baldoni has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
John Baldoni's most recent insider trade was on Sep 1, 2023, when they sold 9,846 shares at $1.46 per share.
Get notified when new Form 4 filings are submitted
| $1.76 |
| Discretionary |
| Mar 1, 2023 | INKT | $14.4K | Award | 6,878 | $2.09 | Discretionary |
| Dec 1, 2022 | INKT | $14.4K | Award | 5,508 | $2.61 | Discretionary |
| Sep 15, 2022 | INKT | $28.8K | Award | 10,974 | $2.62 | Discretionary |